abstract |
Pyrimidine derivatives of formula (I) and n n n the physiologically acceptable salts thereof, n where R1, R2, R3, R4, W, X, Y and Z have the meanings given in claim 1, display a phosphodiesterase V inhibition and can be used for treatment of diseases of the coronary circulatory system and for treatment and/or therapy of potency disorders. |